Utah-based Cancer Therapeutics has taken a 25 percent stake in NanoTherapies, a company that's developing therapies for cancer treatment based on calcium phosphate nanoparticles for therapeutic and diagnostic applications. This is Cancer Therapeutics first acquisition; the company said that it's interested in doing additional deals. Release